Asterias (아스테라시스)
KOSDAQ · KRX: 450950
Asterias is a South Korean biopharmaceutical company that focuses on the development and commercialization of regenerative medicine and cell therapy products. The company is listed on the KOSDAQ market, South Korea's secondary stock exchange for growth-oriented companies. Asterias operates primarily in the advanced therapeutic medicinal products (ATMP) sector, developing treatments based on stem cell and cell therapy technologies.
Filing timeline
highspotted 17:40 KST
Asterias (KRX: 450950)- Reporting party Seo Eun-taek (서은택) holds 17,355,135 shares (45.87% of total)
- Controlled shares total 2,852,246 (7.54%), resulting in combined 23,207,381 shares (53.41%)
- No new acquisitions reported; filing triggered by maturity date extension of share-backed loan facility
View original DART filing ↗AI-generated summaries of public DART filings. May contain errors — always verify against the original (linked). Not investment advice.